Data set on R&D expenditure by industry which addresses the problems of international comparability and breaks in the time series of the official business enterprise R&D data.
A timely set of indicators that reflect the level and structure of the efforts undertaken by OECD member countries and selected non-member economies in the field of science and technology.
The OECD has played a key role in the development of international guidelines for surveys of business innovation and the design of indicators constructed with data from such surveys. In addition to developing methodological guidance, the OECD also carries out analytical studies using innovation-related indicators and microdata.
Indicators include nanotech firms, nanotech R&D, public sector R&D expenditure and nanotechnology patents.
Statistics on biotechnology firms, biotechnology R&D (including public sector expenditures), biotech applications and patents.
This initiative has sought to promote the implementation of a horizontal survey instrument targeting the full population of doctorate holders, rather than specific recent cohorts, as well as covering all institutional sectors of employment, in order to map research skills use economy wide as opposed to focusing on academic careers only. It has sought to address challenges found in other sources.
This electronic publication provides recent statistics on the resources devoted to the R&D in OECD countries and in nine non-member economies.
This paper presents the results of data collection across 18 countries and demonstrates that it is possible to produce new policy relevant indicators on public funding of R&D. Initial findings highlight interesting differences across countries in terms of their approaches to R&D funding.
Measuring the economic and social impacts of the Internet presents several challenges. This working paper reviews the rapidly changing nature of the Internet, the need for more granular data in order to understand its complexity, and the phenomenon of big data.
English, , 287kb
The aim of these guidelines is to propose a harmonised approach for the collection and analysis of biotechnology research and development (R&D) statistics in the government and higher education sectors.